1. Home
  2. VSTM vs IHRT Comparison

VSTM vs IHRT Comparison

Compare VSTM & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • IHRT
  • Stock Information
  • Founded
  • VSTM 2010
  • IHRT 1974
  • Country
  • VSTM United States
  • IHRT United States
  • Employees
  • VSTM N/A
  • IHRT N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • IHRT Broadcasting
  • Sector
  • VSTM Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • VSTM Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • VSTM 313.1M
  • IHRT 310.3M
  • IPO Year
  • VSTM 2012
  • IHRT 2019
  • Fundamental
  • Price
  • VSTM $6.08
  • IHRT $1.65
  • Analyst Decision
  • VSTM Strong Buy
  • IHRT Buy
  • Analyst Count
  • VSTM 8
  • IHRT 3
  • Target Price
  • VSTM $13.00
  • IHRT $2.83
  • AVG Volume (30 Days)
  • VSTM 988.6K
  • IHRT 1.2M
  • Earning Date
  • VSTM 03-20-2025
  • IHRT 05-08-2025
  • Dividend Yield
  • VSTM N/A
  • IHRT N/A
  • EPS Growth
  • VSTM N/A
  • IHRT N/A
  • EPS
  • VSTM N/A
  • IHRT N/A
  • Revenue
  • VSTM $10,000,000.00
  • IHRT $3,854,532,000.00
  • Revenue This Year
  • VSTM N/A
  • IHRT $0.97
  • Revenue Next Year
  • VSTM $867.23
  • IHRT $5.09
  • P/E Ratio
  • VSTM N/A
  • IHRT N/A
  • Revenue Growth
  • VSTM N/A
  • IHRT 2.76
  • 52 Week Low
  • VSTM $2.10
  • IHRT $0.81
  • 52 Week High
  • VSTM $13.52
  • IHRT $2.84
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 42.16
  • IHRT 43.50
  • Support Level
  • VSTM $6.01
  • IHRT $1.43
  • Resistance Level
  • VSTM $6.89
  • IHRT $1.90
  • Average True Range (ATR)
  • VSTM 0.47
  • IHRT 0.14
  • MACD
  • VSTM -0.14
  • IHRT 0.02
  • Stochastic Oscillator
  • VSTM 11.83
  • IHRT 46.81

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: